We are live on ! Find out more
WOC

West Oak Capital Portfolio holdings

AUM $2.52M
1-Year Est. Return 17.57%
This Fund
S&P 500
This Quarter Est. Return
+8.11%
1 Year Est. Return
+17.57%
3 Year Est. Return
+110.25%
5 Year Est. Return
+137.03%
10 Year Est. Return
+334.95%
AUM
$173M
AUM Growth
+$8.83M
Cap. Flow
-$1.31M
Cap. Flow %
-0.76%
Top 10 Hldgs %
28.56%
Holding
387
New
53
Increased
64
Reduced
53
Closed
22

Top Sells

Rank Stock Value
1
SBUX icon
Starbucks
SBUX
+$1.29M
2
T icon
AT&T
T
+$896K
3
VCSH icon
Vanguard Short-Term Corporate Bond ETF
VCSH
+$856K
4
FNB icon
FNB Corp
FNB
+$467K
5
WEC icon
WEC Energy
WEC
+$339K

Sector Composition

Rank Sector Weight
1 Financials 24.79%
2 Technology 19.3%
3 Healthcare 12.84%
4 Industrials 8.68%
5 Consumer Staples 6.33%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CBMG
326
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
$1.81K ﹤0.01%
100
CVA
327
DELISTED
Covanta Holding Corporation
CVA
$1.63K ﹤0.01%
100
SBRA icon
328
Sabra Healthcare REIT
SBRA
$5.38B
$1.43K ﹤0.01%
+62
New +$1.41K
PLSE icon
329
Pulse Biosciences
PLSE
$2.43B
$1.42K ﹤0.01%
100
PIPR icon
330
Piper Sandler
PIPR
$5.15B
$1.3K ﹤0.01%
68
GE icon
331
GE Aerospace
GE
$368B
$1.13K ﹤0.01%
21
SGMO
332
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
$848 ﹤0.01%
50
VTGN icon
333
VistaGen Therapeutics
VTGN
$9.89M
$725 ﹤0.01%
17
STRT icon
334
STRATTEC Security
STRT
$369M
$713 ﹤0.01%
20
EXC icon
335
Exelon
EXC
$46.6B
$699 ﹤0.01%
22
ATHX
336
DELISTED
Athersys, Inc. Common Stock
ATHX
$630 ﹤0.01%
12
LSTA icon
337
Lisata Therapeutics
LSTA
$9.38M
$590 ﹤0.01%
7
BCLI
338
DELISTED
BRAINSTORM CELL THERAPUTC
BCLI
$573 ﹤0.01%
10
PLUR icon
339
Pluri
PLUR
$16.8M
$520 ﹤0.01%
5
GWPH
340
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
$173 ﹤0.01%
1
VC
341
DELISTED
VISTEON CORPORATION
VC
$93 ﹤0.01%
1
BF.B icon
342
Brown-Forman Class B
BF.B
$13.2B
-812
Closed -$39.8K
CBOE icon
343
Cboe Global Markets
CBOE
$31B
-275
Closed -$28.6K
FTV icon
344
Fortive
FTV
$17.7B
-159
Closed -$7.71K
B
345
Barrick Mining
B
$63.2B
-1,000
Closed -$13.1K
IEV icon
346
iShares Europe ETF
IEV
$1.68B
-200
Closed -$8.94K
INDA icon
347
iShares MSCI India ETF
INDA
$6.88B
-300
Closed -$9.99K
KEY icon
348
KeyCorp
KEY
$24.2B
-600
Closed -$11.7K
LX
349
LexinFintech Holdings
LX
$246M
-800
Closed -$9.8K
MAR icon
350
Marriott International
MAR
$99B
-57
Closed -$7.22K

Similar funds

West Oak Capital's Q3 2018 Portfolio in Review

As of Q3 2018, West Oak Capital held 387 positions worth $173M, up 5.4% from $164M the previous quarter. Its ten largest holdings account for 29% of the portfolio.

West Oak Capital's Q3 2018 filing shows 53 new, 64 increased, 53 reduced and 22 closed positions. Its largest new stake was Advanced Micro Devices: 74,075 shares worth $2.29M. The largest sale was Starbucks, an estimated $1.29M.

By sector, the portfolio is most concentrated in Financials at 25% of assets, down from 26% a quarter earlier, followed by Technology and Healthcare.

  • West Oak Capital's largest Q3 2018 buy was Advanced Micro Devices: 74,075 shares worth $2.29M.
  • West Oak Capital added most to Royal Dutch Shell PLC ADS Class A in Q3 2018, an estimated $132K increase.
  • West Oak Capital's biggest Q3 2018 reduction was Starbucks, cutting an estimated $1.29M.
  • West Oak Capital fully exited Vanguard Emerging Markets Government Bond ETF in Q3 2018, selling an estimated $78.2K.
  • West Oak Capital's ten largest holdings make up 29% of its $173M portfolio in Q3 2018.
  • West Oak Capital opened 53 new positions and closed 22 in Q3 2018.
  • West Oak Capital's portfolio value rose 5.4% quarter-over-quarter to $173M.

Based on West Oak Capital's 13F filing for Q3 2018, filed 4 Oct 2018.